Clinical and economic evaluation of a proteomic biomarker preterm birth risk predictor: cost-effectiveness modeling of prenatal interventions applied to predicted higher-risk pregnancies within a large and diverse cohort.

Julja Burchard Glenn R Markenson George R Saade Louise C Laurent Kent D HeyborneDean V CoonrodCorina N SchoenJason K BaxterDavid M HaasSherri A LongoScott A Sullivan Sarahn M WheelerLeonardo M PereiraKim A BoggessAngela F HawkAmy H CrockettRyan TreacyAngela C FoxAshoka D Polpitiya Tracey C Fleischer Thomas J Garite J Jay Boniface John A F ZupancicGregory C CritchfieldPaul E Kearney

Published in: Journal of medical economics (2022)

Modeled evaluation of a biomarker-based test-and-treat strategy in a diverse population predicts clinically and economically meaningful improvements in neonatal and maternal outcomes.

Keyphrases

preterm birth
gestational age
low birth weight
birth weight
pregnant women
adipose tissue
body mass index
preterm infants
weight loss
glycemic control
breast cancer risk